Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.2530
0.00 (0.00%)
Jun 12, 2026, 4:00 PM EST

Bio Essence Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
14291918-
Market Cap Growth
--75.10%-52.74%6.77%--
Enterprise Value
155122323-
Last Close Price
0.250.060.240.510.55-
PE Ratio
7.682.55----
PS Ratio
5.721.2028.28-29.21-
PB Ratio
-9.52-1.10-3.08-11.67-5.61-
P/FCF Ratio
-1.4514.68---
P/OCF Ratio
11.481.4514.68---
EV/Sales Ratio
6.362.4737.88-36.47-
EV/EBITDA Ratio
11.165.21----
EV/EBIT Ratio
11.445.21----
EV/FCF Ratio
-2.9919.67---
Debt / Equity Ratio
-1.10-0.75-0.91-1.98-1.43-1.63
Debt / EBITDA Ratio
1.161.66----
Debt / FCF Ratio
1.321.004.34---
Net Debt / Equity Ratio
-1.07-0.75-0.91-1.98-1.42-1.63
Net Debt / EBITDA Ratio
1.161.74-5.90-9.65-9.29-4.82
Net Debt / FCF Ratio
1.291.004.34-3.20-6.52-2.80
Asset Turnover
4.125.400.21-0.380.50
Inventory Turnover
----1.492.43
Quick Ratio
0.020.010.00-0.000.01
Current Ratio
0.370.170.100.120.060.10
Return on Assets (ROA)
142.99%159.92%-18.89%-10.03%-19.68%-30.24%
Return on Invested Capital (ROIC)
---67.34%-23.01%-35.15%-63.42%
Return on Capital Employed (ROCE)
-96.30%-44.60%18.20%-112.20%25.40%81.10%
Earnings Yield
9.62%39.30%-14.29%-5.01%-4.46%-
FCF Yield
-68.83%6.81%-5.31%-3.89%-
Buyback Yield / Dilution
-4.57%--11.94%-2.86%-0.08%